JPWO2019079299A5 - - Google Patents

Info

Publication number
JPWO2019079299A5
JPWO2019079299A5 JP2020521319A JP2020521319A JPWO2019079299A5 JP WO2019079299 A5 JPWO2019079299 A5 JP WO2019079299A5 JP 2020521319 A JP2020521319 A JP 2020521319A JP 2020521319 A JP2020521319 A JP 2020521319A JP WO2019079299 A5 JPWO2019079299 A5 JP WO2019079299A5
Authority
JP
Japan
Prior art keywords
cancer
crystals
degrees
fluorobenzofuran
dioxolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020521319A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020536944A (ja
JP2020536944A5 (https=
JP7776258B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/056083 external-priority patent/WO2019079299A1/en
Publication of JP2020536944A publication Critical patent/JP2020536944A/ja
Priority to JP2023151499A priority Critical patent/JP2024001040A/ja
Publication of JP2020536944A5 publication Critical patent/JP2020536944A5/ja
Publication of JPWO2019079299A5 publication Critical patent/JPWO2019079299A5/ja
Application granted granted Critical
Publication of JP7776258B2 publication Critical patent/JP7776258B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020521319A 2017-10-16 2018-10-16 ３－（５－フルオロベンゾフラン－３－イル）－４－（５－メチル－５Ｈ－［１，３］ジオキソロ［４，５－ｆ］インドール－７－イル）ピロール－２，５－ジオンの固体形態 Active JP7776258B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023151499A JP2024001040A (ja) 2017-10-16 2023-09-19 ３－（５－フルオロベンゾフラン－３－イル）－４－（５－メチル－５Ｈ－［１，３］ジオキソロ［４，５－ｆ］インドール－７－イル）ピロール－２，５－ジオンの固体形態

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762572603P 2017-10-16 2017-10-16
US62/572,603 2017-10-16
PCT/US2018/056083 WO2019079299A1 (en) 2017-10-16 2018-10-16 SOLID FORMS OF 3- (5-FLUOROBENZOFURAN-3-YL) -4- (5-METHYL-5H- [1,3] DIOXOLO [4,5-F] INDOL-7-YL) PYRROLE-2,5-DIONE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023151499A Division JP2024001040A (ja) 2017-10-16 2023-09-19 ３－（５－フルオロベンゾフラン－３－イル）－４－（５－メチル－５Ｈ－［１，３］ジオキソロ［４，５－ｆ］インドール－７－イル）ピロール－２，５－ジオンの固体形態

Publications (4)

Publication Number Publication Date
JP2020536944A JP2020536944A (ja) 2020-12-17
JP2020536944A5 JP2020536944A5 (https=) 2025-09-10
JPWO2019079299A5 true JPWO2019079299A5 (https=) 2025-09-10
JP7776258B2 JP7776258B2 (ja) 2025-11-26

Family

ID=64110166

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020521319A Active JP7776258B2 (ja) 2017-10-16 2018-10-16 ３－（５－フルオロベンゾフラン－３－イル）－４－（５－メチル－５Ｈ－［１，３］ジオキソロ［４，５－ｆ］インドール－７－イル）ピロール－２，５－ジオンの固体形態
JP2023151499A Pending JP2024001040A (ja) 2017-10-16 2023-09-19 ３－（５－フルオロベンゾフラン－３－イル）－４－（５－メチル－５Ｈ－［１，３］ジオキソロ［４，５－ｆ］インドール－７－イル）ピロール－２，５－ジオンの固体形態

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023151499A Pending JP2024001040A (ja) 2017-10-16 2023-09-19 ３－（５－フルオロベンゾフラン－３－イル）－４－（５－メチル－５Ｈ－［１，３］ジオキソロ［４，５－ｆ］インドール－７－イル）ピロール－２，５－ジオンの固体形態

Country Status (16)

Country Link
US (3) US11407759B2 (https=)
EP (1) EP3697794B1 (https=)
JP (2) JP7776258B2 (https=)
KR (1) KR102891811B1 (https=)
CN (1) CN111315748B (https=)
AU (1) AU2018352384B2 (https=)
CA (1) CA3074037A1 (https=)
DK (1) DK3697794T3 (https=)
ES (1) ES3064009T3 (https=)
FI (1) FI3697794T3 (https=)
IL (1) IL273920B2 (https=)
MX (1) MX2020003431A (https=)
PL (1) PL3697794T3 (https=)
PT (1) PT3697794T (https=)
WO (1) WO2019079299A1 (https=)
ZA (1) ZA202002740B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3697794T3 (pl) * 2017-10-16 2026-04-07 Actuate Therapeutics Inc. Stałe postacie 3-(5-fluorobenzofuran-3-ylo)-4-(5-metylo-5h-[1,3]dioksolo[4,5-f]indol-7-ilo)pirolo-2,5-dionu
WO2019222483A1 (en) * 2018-05-17 2019-11-21 Board Of Regents, The University Of Texas System Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form beta inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2673368C (en) 2006-12-19 2014-10-28 The Board Of Trustees Of The University Of Illinois 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders
EP3665176B1 (en) * 2017-08-11 2024-01-24 Actuate Therapeutics Inc. Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5h[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione
PL3697794T3 (pl) * 2017-10-16 2026-04-07 Actuate Therapeutics Inc. Stałe postacie 3-(5-fluorobenzofuran-3-ylo)-4-(5-metylo-5h-[1,3]dioksolo[4,5-f]indol-7-ilo)pirolo-2,5-dionu

Similar Documents

Publication Publication Date Title
JP2022186995A5 (https=)
ES2351958T3 (es) 5-cloro-3-(4-metanosulfonilfenil)-6'-metil-[2,3'] bipiridinil en forma cristalina pura y procedimiento de síntesis.
RU2603138C1 (ru) Кристаллическая форма хидамида, способ ее получения и применение
JP7682923B2 (ja) ゲポチダシンの結晶形態
JP2020536893A5 (https=)
JP2023528565A (ja) Ｇｌｐ－１受容体アゴニストの結晶形ａおよびその調製法
KR20190039823A (ko) 키나아제 억제제 화합물의 다결정형(polymorphic form), 이를 함유한 약물 조성물 및 그의 제조방법과 응용
JP2024001040A5 (https=)
JP2023156372A5 (https=)
JPWO2020165646A5 (https=)
JPWO2019079299A5 (https=)
JPWO2020051538A5 (https=)
JP2005529084A5 (https=)
CN111247153B (zh) 3-(5-氟苯并呋喃-3-基)-4-(5-甲基-5H-[1，3]间二氧杂环戊烯并[4，5-f]吲哚-7-基)吡咯-2，5-二酮的固体形式
JPWO2020069024A5 (https=)
WO2019195569A1 (en) Solid-state forms of abemaciclib, their use and preparation
CN114450278B (zh) 一个烟醇醚衍生物的马来酸盐及其晶型和应用
KR20130119844A (ko) 글리코피로늄 클로라이드의 결정형
WO2014036953A1 (zh) 用于抗肿瘤药物的芳香脲的晶型及其制备方法
CN111315748B (zh) 3-(5-氟苯并呋喃-3-基)-4-(5-甲基-5H-[1,3]间二氧杂环戊烯并[4,5-f]吲哚-7-基)吡咯-2,5-二酮晶体
CN108003081B (zh) 一种斯诺普利单水合物晶体及其制备方法
CN116253695B (zh) Hsp90抑制剂及其制备方法和用途
JPWO2002083633A1 (ja) トシル酸スプラタスト結晶
TW200530250A (en) Novel compound, corresponding compositions, preparation and/or treatment methods
WO2023047424A1 (en) Pharmaceutical acceptable iron (iii) coordination complex having high phosphate binding capacity and preparation thereof